Bank of New York Mellon Corp Raises Holdings in Keros Therapeutics, Inc. (NASDAQ:KROS)
Bank of New York Mellon Corp increased its position in shares of Keros Therapeutics, Inc. (NASDAQ:KROS – Free Report) by 2.6% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 97,878 shares of the company’s stock after purchasing an additional 2,462 shares during the quarter. Bank of […]
Bank of New York Mellon Corp increased its position in shares of Keros Therapeutics, Inc. (NASDAQ:KROS – Free Report) by 2.6% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 97,878 shares of the company’s stock after purchasing an additional 2,462 shares during the quarter. Bank of […]
